Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ENDOXAN INJ for Diffuse large b-cell lymphoma: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 88 adverse event reports in the FDA FAERS database where ENDOXAN INJ was used for Diffuse large b-cell lymphoma.

Most Reported Side Effects for ENDOXAN INJ

Side Effect Reports % Deaths Hosp.
Disease progression 64 59.8% 36 0
Death 15 14.0% 15 0
Febrile neutropenia 11 10.3% 11 0
T-cell lymphoma recurrent 10 9.4% 0 0
Adverse event 8 7.5% 8 0
Pneumonia 5 4.7% 5 0

Other Indications for ENDOXAN INJ

Plasma cell myeloma (18)

Other Drugs Used for Diffuse large b-cell lymphoma

RITUXIMAB (22,275) CYCLOPHOSPHAMIDE (16,598) DOXORUBICIN (15,213) VINCRISTINE (14,922) PREDNISONE (11,266) LENALIDOMIDE (7,858) ETOPOSIDE (4,698) PREDNISOLONE (4,086) CYTARABINE (3,857) DEXAMETHASONE (3,696)

Related Pages

ENDOXAN INJ Full Profile All Diffuse large b-cell lymphoma Drugs ENDOXAN INJ Demographics ENDOXAN INJ Timeline